Sophia Genetics Sa (SOPH)

概要ニュース株価時系列オプションチェーンディスカッション予測

Relative Volume:

ネットキャッシュフロー:

Sophia Genetics Sa Stock (SOPH) Company Profile

Sophia Genetics Sa

Healthcare (1111)

SOPH's Discussions on Twitter

Compare SOPH vs VEEV, BTSG, TEM, HQY, DOCS

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
SOPH Sophia Genetics Sa	5.02	359.78M	77.27M	-79.00M	-48.46M	-1.1694
VEEV Veeva Systems Inc	167.35	27.94B	3.20B	908.91M	1.39B	5.4168
BTSG Brightspring Health Services Inc	52.74	9.98B	13.65B	169.86M	412.12M	1.0758
TEM Tempus Ai Inc	53.50	9.70B	1.27B	-245.03M	-245.36M	-1.4071
HQY Healthequity Inc	83.25	6.98B	1.31B	215.20M	408.32M	2.4627
DOCS Doximity Inc	25.69	4.76B	637.78M	239.40M	307.21M	1.1909

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2024-12-18	開始されました	Craig Hallum	Buy
2024-08-07	ダウングレード	Morgan Stanley	Overweight → Equal-Weight
2024-06-27	開始されました	Guggenheim	Buy
2023-11-29	開始されました	RBC Capital Mkts	Outperform
2023-07-05	再開されました	JP Morgan	Overweight
2023-01-03	開始されました	BTIG Research	Buy
2022-11-23	開始されました	Credit Suisse	Neutral
2021-10-15	再開されました	Cowen	Outperform
2021-08-17	開始されました	Cowen	Outperform
2021-08-17	開始されました	Credit Suisse	Outperform
2021-08-17	開始されました	JP Morgan	Overweight
2021-08-17	開始されました	Morgan Stanley	Overweight

Sophia Genetics Sa (SOPH) 最新ニュース

Sophia Genetics Sa (SOPH) 財務データ

Sophia Genetics Sa (SOPH)

Sophia Genetics Sa Stock (SOPH) Company Profile

Compare SOPH vs VEEV, BTSG, TEM, HQY, DOCS

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Sophia Genetics Sa (SOPH) 最新ニュース

SOPHiA GENETICS (NASDAQ:SOPH) Earns Buy Rating from BTIG Research - MarketBeat

SOPHiA GENETICS S.A. (NASDAQ:SOPH) Q1 2026 Earnings Call Transcript - Insider Monkey

BTIG reiterates Sophia Genetics stock rating on strong Q1 growth By Investing.com - Investing.com Australia

SOPHiA GENETICS Earnings Call: Growth With Caveats - TipRanks

SOPHiA GENETICS S.A. Q1 2026 Earnings Call Summary - Yahoo Finance

SOPHiA GENETICS Q1 Earnings Call Highlights - MarketBeat

SOPHiA GENETICS (NASDAQ:SOPH) Releases Quarterly Earnings Results, Misses Estimates By $0.04 EPS - MarketBeat

SOPHiA GENETICS SA reports results for the quarter ended March 31Earnings Summary - TradingView

BTIG Raises its Price Target on SOPHiA GENETICS (SOPH) to $8 - Insider Monkey

SOPHiA GENETICS Posts Higher Q1 2026 Revenue but Wider Loss in Newly Filed Form 6-K - TipRanks

SOPH: Q1 2026 revenue up 22% year-over-year, with improved margins and strong global expansion - TradingView

SOPHiA GENETICS SA Reaffirms Earnings Guidance for the Fiscal Year 2026 - marketscreener.com

SOPHiA GENETICS (SOPH) grows Q1 2026 revenue 22% but remains loss-making - Stock Titan

SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $24,100.00 in Stock - MarketBeat

SOPHiA GENETICS (SOPH) CMO sells 5,000 shares under 10b5-1 plan - Stock Titan

Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Drops By 31.0% - MarketBeat

SOPHiA GENETICS (SOPH) Projected to Post Earnings on Tuesday - MarketBeat

SOPH Price Today: SOPHiA GENETICS SA Stock Price, Quote & Chart | MEXC - MEXC Exchange

Tangible book value per share of SOPHiA GENETICS SA – LS:A3CVT8 - TradingView

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results (PR Newswire) - Aktiellt

SOPHiA (SOPH) Industry Outlook | SOPHiA GENETICS SA misses EPS by 3.2% on $77.3M revenueProfit - Cổng thông tin điện tử tỉnh Lào Cai

Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) CEO Sells 4,486 Shares of Stock - MarketBeat

SOPHiA GENETICS (SOPH) HR chief sells 380 shares to cover RSU taxes - Stock Titan

SOPHiA GENETICS (SOPH) CSO sells 608 shares under 10b5-1 plan - Stock Titan

SOPHiA GENETICS (SOPH) legal chief sells 684 shares for tax withholding - Stock Titan

CEO’s tax-driven share sale at SOPHiA GENETICS (SOPH) detailed - Stock Titan

SOPHiA GENETICS (SOPH) CMO tax-related sale of 608 shares under 10b5-1 plan - Stock Titan

Tax-driven SOPHiA GENETICS (SOPH) insider sale under Rule 10b5-1 plan - Stock Titan

Tax-related sell-to-cover by SOPHiA GENETICS (SOPH) Chief Sales Officer - Stock Titan

SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026 - Finviz

Multiple 10b5-1 sales by SOPH insider (NASDAQ: SOPH) reported - Stock Titan

[144] SOPHiA GENETICS SA SEC Filing - Stock Titan

SOPH (NASDAQ: SOPH) lists 10b5-1 sales including 3,824 shares on 04/08/2026 - Stock Titan

Multiple 10b5‑1 insider sales reported at SOPH (NASDAQ: SOPH) - Stock Titan

760-share Rule 144 notice; SOPH (NASDAQ: SOPH) lists 10b5-1 trades Feb–Apr 2026 - Stock Titan

SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - MarketBeat

Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026 - Sahm

Insider Sell: Zhenyu Xu Sells Shares of Sophia Genetics SA - GuruFocus

Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) President Sells 2,800 Shares of Stock - MarketBeat

Jurgi Camblong Sells 43,129 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat

SOPHiA GENETICS (NASDAQ:SOPH) CEO Sells $87,365.00 in Stock - MarketBeat

SOPHiA GENETICS (SOPH) CSO executes 600-share Rule 10b5-1 sale - Stock Titan

SOPHiA GENETICS (SOPH) CEO’s 60,602-share sale funds RSU tax withholding - Stock Titan

[Form 4] SOPHiA GENETICS SA Insider Trading Activity - Stock Titan

SOPHiA GENETICS (SOPH) president sells 2,800 shares under Rule 10b5-1 tax plan - Stock Titan

SOPH SEC FilingsSophia Genetics Sa 10-K, 10-Q, 8-K Forms - Stock Titan

Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026 – Company AnnouncementFT.com - Financial Times

SOPH Maintained by BTIG -- Price Target Raised to $8.00 - GuruFocus

BTIG raises Sophia Genetics stock price target on data strategy By Investing.com - Investing.com Australia

SOPHiA GENETICS (NASDAQ:SOPH) Insider Zhenyu Xu Sells 3,706 Shares - MarketBeat

Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) President Sells 3,687 Shares of Stock - MarketBeat

Sophia Genetics Sa (SOPH) 財務データ

収益

当期純利益

現金流量

EPS

SOPHに似た銘柄